Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Guangzhou Baiyunshan Pharmaceutical Holdings Company ( (HK:0874) ) just unveiled an announcement.
Guangzhou Baiyunshan Pharmaceutical Holdings Company has appointed Mr. Chen Jiehui as the vice chairperson of its board, effective from September 26, 2025. Mr. Chen, who has extensive experience in strategic management and corporate governance, will serve until the conclusion of the board’s ninth session. This appointment is expected to strengthen the company’s leadership and strategic direction, potentially impacting its industry positioning and stakeholder relationships.
The most recent analyst rating on (HK:0874) stock is a Buy with a HK$21.50 price target. To see the full list of analyst forecasts on Guangzhou Baiyunshan Pharmaceutical Holdings Company stock, see the HK:0874 Stock Forecast page.
More about Guangzhou Baiyunshan Pharmaceutical Holdings Company
Guangzhou Baiyunshan Pharmaceutical Holdings Company is a joint stock company based in China, operating within the pharmaceutical industry. The company focuses on the production and distribution of pharmaceutical products, serving a broad market within the healthcare sector.
YTD Price Performance: 3.65%
Average Trading Volume: 1,769,764
Technical Sentiment Signal: Buy
Current Market Cap: HK$42.86B
See more data about 0874 stock on TipRanks’ Stock Analysis page.